Drug Target Review2025-07-01T08:30:20
Researchers at the University of North Carolina at Charlotte have used artificial intelligence to look at how the H5N1 bird flu virus is evolving to evade the immune system - insights that could make way for development of effective future therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-04T16:00:00Z
Sponsored by Cell Signaling Technology and Myllia
2026-09-10T08:41:00Z
Sponsored by DNA Genotek Inc.
2024-01-19T07:40:55
Sponsored by Euretos
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2026-11-11T14:00:00
Sponsored by Cell Signaling Technology
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2026-09-23T15:00:00
Sponsored by BioIVT
Site powered by Webvision Cloud